Olanzapine in the Management of Chorea
Olanzapine is an effective treatment option for chorea, particularly beneficial in Huntington's disease, with recommended starting doses of 2.5-5 mg daily and potential benefit from higher doses (up to 30 mg) in severe cases. 1, 2
Mechanism and Clinical Efficacy
- Olanzapine works by antagonizing multiple receptors involved in movement disorders, particularly dopamine D2 receptors, which helps control choreatic movements 1
- In severe chorea, high-dose olanzapine (up to 30 mg daily) has demonstrated significant improvement in motor symptoms, allowing patients to regain functional abilities such as eating and walking independently 2
- Olanzapine has shown comparable efficacy to tetrabenazine for controlling Huntington's chorea, with patients on olanzapine showing a slower annual worsening of motor symptoms (3.20 points) compared to matched tetrabenazine groups (5.70 points) 3
Dosing Protocol and Titration
- Start with 2.5-5 mg daily, with gradual upward titration based on clinical response and tolerability 1
- Lower starting doses should be used in elderly patients or those with hepatic impairment 1
- In cases of severe chorea that doesn't respond to standard doses, higher doses up to 30 mg daily may be considered, as significant improvement has been documented at this dosage 2, 4
- For optimal management of sleep disturbances, the highest daily dose can be administered at night to leverage the sedative effects 5
Clinical Applications Beyond Huntington's Disease
- Olanzapine may be beneficial in chorea associated with:
- Particularly valuable in patients with concurrent weight loss and chorea, as olanzapine can help address both symptoms simultaneously 5
Monitoring and Side Effect Management
- Regular monitoring is essential for:
Important Precautions and Contraindications
- Avoid combining olanzapine with benzodiazepines when possible, as fatalities have been reported with this combination 1, 6, 7
- Use with caution in:
- Patients with Parkinson's disease or dementia with Lewy bodies due to increased risk of extrapyramidal symptoms 1, 6
- Elderly patients, particularly those with dementia-related psychosis (boxed warning for increased mortality) 6
- Patients with cardiovascular disease due to potential effects on cardiac conduction 6
- Patients with severe hepatic impairment 6
Combination Therapy Approaches
- When using olanzapine with other medications, be vigilant for additive side effects, particularly excessive sedation and extrapyramidal symptoms 1
- In Huntington's disease with severe chorea, some clinicians combine antidopaminergic drugs with different mechanisms (e.g., a postsynaptic agent like tiapride with a presynaptic agent like tetrabenazine) 5
- When combining olanzapine with other antipsychotics, use lower doses of both medications to minimize adverse effects 6
Clinical Pearls
- Olanzapine can be particularly beneficial when chorea co-occurs with psychiatric symptoms or weight loss 5
- Myoclonus in Huntington's disease is often misdiagnosed as chorea but may respond better to valproic acid than to antidopaminergic medications like olanzapine 8
- The sedative effects of olanzapine can be therapeutically leveraged by administering the highest daily dose at night to improve sleep disturbances 5